Olema Pharmaceuticals Inc (OLMA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $24.39
• Market Cap: $1.93B
• EPS: $-1.76
• 52-Week High: $36.26
• 52-Week Low: $2.86

Market Sentiment

Olema Pharmaceuticals Inc currently has a Bullish sentiment score of 0.33.

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of targeted therapies for women's cancers. With a commitment to addressing substantial unmet medical needs in a historically underrepresented patient demographic, Olema is advancing an innovative pipeline of novel compounds aimed at improving patient outcomes. The company is strategically positioned within the oncology sector as it pro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Olema Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OLMA pay dividends?

Olema Pharmaceuticals Inc (OLMA) does not currently pay a regular dividend.

What is OLMA's market cap?

Olema Pharmaceuticals Inc (OLMA) has a market capitalization of $1.93B with a current stock price of $24.39.